Koronis Pharmaceuticals
Koronis Pharmaceuticals, based in Seattle, WA, is dedicated to developing innovative technologies for the prevention and treatment of chronic viral diseases, with a particular focus on HIV, hepatitis B, and hepatitis C viruses. By acquiring rights to two unique antiviral platforms from the University of Washington, Koronis aims to address the urgent medical need for novel therapeutics amidst the growing issue of viral resistance.
The company's lead product candidate, KP-1461, employs a groundbreaking approach known as Viral Decay Acceleration (VDA), increasing the natural mutation rate of viruses to ultimately induce collapse of the viral population. With a commitment to advancing biotechnology solutions, Koronis Pharmaceuticals actively contributes to the development of effective treatments for viral infections while addressing the challenges posed by resistance.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.